Skip navigation
News & Events

News

Media Contact: Jon Zurbey, Haberman & Associates, 612-338-3900

January 16, 2007

BioE Awarded Patent for Cell Separation Compositions Used to Obtain Company's Category Defining Cord Blood Stem Cell

Patent further defines PrepaCyte cell separation platform for isolating MLPCs and other therapeutically important cells from human blood sources

October 31, 2006

Cytotherapy Report Confirms BioE Stem Cell First Human Cord Blood Stem Cell to Differentiate into Lung Cell

BioE and University of Minnesota extend stem cell research agreement to further evaluate MLPC to treat lung injuries and respiratory disease

October 30, 2006

BioE Wins 2006 Tekne Award for "Remarkable" Stem Cell Advancements and "Smart Business Model"

Award program honors companies, innovations and individuals that positively impact Minnesota's technology-based economy

September 26, 2006

BioE Executives to Present at 35th Annual International Society for Experimental Hematology Meeting

Company to participate in IP and marketing symposium and present scientific data further demonstrating the MLPC’s potential as a new, powerful tool for regenerative medicine and drug screening

September 7, 2006

BioE Stem Cell to be Featured in Two Scientific Presentations at the Vatican

UK scientists to present findings on company’s cord blood MLPC, a new category of versatile stem cells that provide vast opportunities for regenerative medicine research

May 30, 2006

BioE and University of Newcastle Form Research Partnership

Collaboration to establish optimal protocols for isolating cord blood cells; researchers aim to source a variety of cord blood stem cells for therapeutic applications and drug discovery

May 17, 2006

BioE and South Eastern Sydney Illawarra Area Health Service Initiate Stem Cell Research Partnership

Collaboration to focus on evaluating potential of BioE’s cord blood stem cell to differentiate into insulin-producing pancreatic cells absent in Type 1 diabetes patients

May 15, 2006

BioE Names National Marrow Donor Program Medical Director to Board of Directors

Dr. John P. Miller’s extensive clinical knowledge will help BioE strengthen its business by facilitating the use of cord blood to enhance patient outcomes

May 8, 2006

BioE Stem Cell First Human Cord Blood Stem Cell to Turn Into Lung Cell

University of Minnesota researchers differentiate MLPC into type II alveolar cells; studies continue to evaluate clinical and therapeutic potential of rare cord blood stem cell to treat respiratory conditions

May 3, 2006

BioE Appoints Gayl Rogers Chrysler Vice President of Cellular Technologies and Clinical Affairs

Former National Director of Operations for the National American Red Cross’ Cord Blood Program brings unparalleled cord blood expertise to emerging biomedical leader